146 related articles for article (PubMed ID: 18275676)
21. Proteomic identification and profiling of canine lymphoma patients.
Ratcliffe L; Mian S; Slater K; King H; Napolitano M; Aucoin D; Mobasheri A
Vet Comp Oncol; 2009 Jun; 7(2):92-105. PubMed ID: 19453363
[TBL] [Abstract][Full Text] [Related]
22. The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?
Bilici A; Yapici HS; Ercan S; Seker M; Ustaalioglu BB; Salman T; Orcun A; Gumus M
J BUON; 2012; 17(3):502-7. PubMed ID: 23033289
[TBL] [Abstract][Full Text] [Related]
23. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
24. Characterization of anti-erythrocyte autoantibodies in non-Hodgkin's lymphoma patients in Brazil.
Barjas de Castro ML; Locatelli MF; de Castilho LM; de Souza CA
Haematologia (Budap); 1998; 29(2):139-45. PubMed ID: 9728806
[TBL] [Abstract][Full Text] [Related]
25. Short monolithic columns for purification and fractionation of peptide samples for matrix-assisted laser desorption/ionization time-of-flight/time-of-flight mass spectrometry analysis in proteomics.
Moravcová D; Kahle V; Rehulková H; Chmelík J; Rehulka P
J Chromatogr A; 2009 Apr; 1216(17):3629-36. PubMed ID: 19217112
[TBL] [Abstract][Full Text] [Related]
26. Protein expression pattern distinguishes different lymphoid neoplasms.
Fujii K; Kondo T; Yokoo H; Yamada T; Matsuno Y; Iwatsuki K; Hirohashi S
Proteomics; 2005 Nov; 5(16):4274-86. PubMed ID: 16206328
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma.
Cuttner J; Spiera H; Troy K; Wallenstein S
J Rheumatol; 2005 Oct; 32(10):1884-7. PubMed ID: 16206341
[TBL] [Abstract][Full Text] [Related]
28. Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome.
Braus BK; Hauck SM; Amann B; Heinrich C; Fritsche J; Köstlin R; Deeg CA
Vet Immunol Immunopathol; 2008 Jul; 124(1-2):177-83. PubMed ID: 18405980
[TBL] [Abstract][Full Text] [Related]
29. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
[TBL] [Abstract][Full Text] [Related]
30. Reconstitution of self-reactive antibody repertoires of autologous plasma IgM in patients with non-Hodgkin's lymphoma following myeloablative therapy.
Stahl D; Yeshurun M; Gorin NC; Sibrowski W; Kaveri SV; Kazatchkine MD
Clin Immunol; 2001 Jan; 98(1):31-8. PubMed ID: 11141324
[TBL] [Abstract][Full Text] [Related]
31. Antibodies against extractable nuclear antigen in non-Hodgkin lymphoma patients.
Gergely L; Dankó A; Csípõ I; Váróczy L; Sipka S; Zeher M; Illés A
Scand J Immunol; 2005 Apr; 61(4):343-6. PubMed ID: 15853917
[TBL] [Abstract][Full Text] [Related]
32. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma.
Kolialexi A; Tsangaris GT; Papantoniou N; Anagnostopoulos AK; Vougas K; Bagiokos V; Antsaklis A; Mavrou A
Prenat Diagn; 2008 Aug; 28(8):691-8. PubMed ID: 18551720
[TBL] [Abstract][Full Text] [Related]
33. Search for and identification of novel tumor-associated autoantigens.
Conrad K; Bartsch H; Canzler U; Pilarsky C; Grützmann R; Bachmann M
Methods Mol Biol; 2010; 576():213-30. PubMed ID: 19882265
[TBL] [Abstract][Full Text] [Related]
34. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
35. Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry.
Park JS; Oh KJ; Norwitz ER; Han JS; Choi HJ; Seong HS; Kang YD; Park CW; Kim BJ; Jun JK; Syn HC
Reprod Sci; 2008 May; 15(5):457-68. PubMed ID: 18579854
[TBL] [Abstract][Full Text] [Related]
36. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
37. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune markers in lymphoid malignancies.
Sjöberg K; Roth EB; Gustavsson L; Jönsson C; Simán H; Henriksson G; Stenberg P; Lindblom A; Svensson P
Scand J Immunol; 2008 May; 67(5):509-15. PubMed ID: 18405328
[TBL] [Abstract][Full Text] [Related]
39. [Non-Hodgkin's lymphoma associated with cold agglutinin disease].
Niitsu N; Nakayama M; Kato M; Umeda M
Rinsho Ketsueki; 1997 Jul; 38(7):587-92. PubMed ID: 9267162
[TBL] [Abstract][Full Text] [Related]
40. Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins.
Li B; An HJ; Kirmiz C; Lebrilla CB; Lam KS; Miyamoto S
J Proteome Res; 2008 Sep; 7(9):3776-88. PubMed ID: 18642944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
